# Prevention of Recurrence After Thrombolysis in Acute Iliofemoral Venous Thrombosis (PRAIS) Study

> **NCT01986192** · NA · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 72 (estimated)

## Conditions studied

- Ileofemoral Deep Vein Thrombosis

## Interventions

- **DRUG:** rivaroxaban
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT01986192
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2015-02
- **Final completion:** 2015-11
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2014-11-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01986192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01986192, "Prevention of Recurrence After Thrombolysis in Acute Iliofemoral Venous Thrombosis (PRAIS) Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01986192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*